20 results
IDSA Treatment of Necrotizing Infections of the Skin, Fascia, and Muscle
 • Mixed infections
 • Streptococcus
IDSA Treatment of ... of the Skin, Fascia ... #fasciitis #Skin ... #management #antibiotics ... #pharmacology
Necrotizing Fasciitis: African-American patient with diabetes that predisposed him to rapidly 
progressive infection. Lower extremity is
Necrotizing Fasciitis ... As the infection ... occurs deep to the skin ... #Photo #Dermatology ... #UCSDH
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
Drugs Used for the ... -19 Infection ... highlighted circle= clinical ... #COVID19 #Pharmacology ... #Table #Management
Necrotizing Fasciitis: Severe infection which travels in the suprafacial plane. In this instance, the infection
started in
Necrotizing Fasciitis ... apparent in the skin ... Images #Clinical ... #Photo #Necrotizing ... #UCSDH
Abscess: Marked swelling and redness is apparent just above antecubital fossa. This is caused by an
innoculated under the skin ... during injection ... drug abuse. ... Images #Clinical ... #Photo #Abscess
Secondary Syphilis Rash
Secondary syphilis is the most contagious of all the stages of this disease, and
Skin rash and malaise ... , but without treatment ... , the infection ... Rash #Diagnosis #Clinical ... #Photo #Dermatology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... are contacts of infectious ... Tuberculosis #MDRTB #management ... #regimens #pharmacology
Aplastic Anemia - Overview

Who?
• M = F
• 3 peaks:	1) Childhood	2) 15-25 years	3) >60 years

What?
• Aplastic anemia
Aplastic Anemia Clinical ... Headaches • Pale skin ... , eosinophilic fasciitis ... aplastic anemia Treatment ... hematology #diagnosis #management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
drug use • Silicosis ... characteristic features Clinical ... • Tuberculin skin ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
drug use • Silicosis ... characteristic features Clinical ... • Tuberculin skin ... TB #Diagnosis #Management ... #Treatment #ActiveTB